Authors



Celia Proctor, PharmD, MBA

Latest:

Limited Distribution Networks Stifle Competition in the Generic and Biosimilar Drug Industries

A limited distribution network is a pharmaceutical distribution strategy that some drug companies have capitalized upon to obstruct generic and biosimilar competition.






Adam Tremblay, MD

Latest:

Measuring Patient-Centered Medical Home Access and Continuity in Clinics With Part-Time Clinicians

Commonly used measures of performance for assessing patient access do not reflect PCMH-encouraged strategies to improve access that may be preferentially used by part-time physicians.




Dana Gelb Safran, ScD

Latest:

Improving Partnerships Between Health Plans and Medical Groups

To provide guidance for successful partnerships, the authors identify common themes from their experience with successful health plan/medical group partnerships programs.



Randi Chen, MS

Latest:

Health Information Technology and Physicians' Knowledge of Drug Costs

High rates of health information technology use by physicians were only modestly associated with better knowledge of drug costs.


Daryl Pritchard, PhD

Latest:

One Size Does Not Always Fit All in Value Assessment

Laying a clear path for incorporating reliable evidence on heterogeneity in value assessments could improve their applicability for healthcare decision making.



Nancy J. Maggard, MSN, RN, NE-BC

Latest:

Postacute Care Partnerships and Patient Progression

Postacute care partners are required for successful patient transitions. Collaboration among multidisciplinary teams and community resources is critical for discharge planning and partnership alignment.


Azeemuddin Ahmed, MD, MBA

Latest:

Against the Current: Back-Transfer as a Mechanism for Rural Regionalization

The authors investigated back-transfer: the transfer of patients near the end of an acute hospitalization to a local community hospital for completion of their medical care.


John W. Newcomer, MD

Latest:

Treatment of Diabetes Mellitus: The Urgent Need for Multifactorial Interventions

The pandemic of type 2 diabetes mellitus requires implementation of multifactorial interventions by clinicians for individual patients and policy makers for the health of the general public.


Annie Guerin, MSc

Latest:

Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung Cancer

This review assesses the current molecular testing landscape for non–small-cell lung cancer in the United States.



Katherine Frey, MPH

Latest:

Guided Care and the Cost of Complex Healthcare: A Preliminary Report

The early months of a cluster-randomized trial suggest that Guided Care is associated with a trend toward a net reduction in total healthcare expenditures.


Douglas Thornton, PharmD, PhD

Latest:

Increased Healthcare Utilization and Expenditures Associated With Chronic Opioid Therapy

The increase in healthcare utilization and expenditures associated with the transition to chronic opioid therapy places increased burden on payers and patients.




David Edelman, MD

Latest:

Long-Term Outcomes of Analogue Insulin Compared With NPH for Patients With Type 2 Diabetes Mellitus

There were no significant differences in the risk of ambulatory care—sensitive condition hospitalization or mortality between patients who initiated analogue insulin compared with the neutral protamine Hagedorn.


Judith Tsamir, MA

Latest:

Can a Nationwide Media Campaign Affect Antibiotic Use?

A nationwide media campaign aimed at parents was associated with reductions in the use of antibiotics for pediatric upper respiratory infections, otitis media, and pharyngitis.


Daniel M. Horn, MD

Latest:

Chronic Disease Management in the COVID-19 Era

In the coronavirus disease 2019 (COVID-19) era, clinical registries and innovative virtual care delivery tools should be leveraged to engage populations in effective chronic disease management.



Hye-Young Jung, PhD

Latest:

The Patient-Driven Payment Model: Addressing Perverse Incentives, Creating New Ones

The Patient-Driven Payment Model addresses perverse incentives in Medicare’s previous payment system for skilled nursing facilities, but it includes new incentives that may be problematic.


Niall Brennan, MPP

Latest:

Comparing Quality of Care in the Medicare Program

Quality measures showed large, though mixed, differences between Medicare fee-for-service and Medicare Advantage programs.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo